Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
European Journal of Endocrinology
|
April 14, 2018
Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism
Wilmar Wiersinga, Miloš Žarković, Luigi Bartalena, et al.
The New England Journal of Medicine
|
May 4, 2017
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J Smith, George J Kahaly, Daniel G Ezra, et al.
Ophthalmology
|
October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study
Raymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
The New England Journal of Medicine
|
January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye Disease
Raymond S Douglas, George J Kahaly, Amy Patel, et al.
European Journal of Endocrinology
|
February 27, 2008
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Luigi Bartalena, Lelio Baldeschi, Alison Dickinson, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 18, 2008
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy
Luigi Bartalena, Lelio Baldeschi, Alison J Dickinson, et al.
The British Journal of Ophthalmology
|
January 10, 2023
Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)
Anna Schuh, Goksun Ayvaz, Lelio Baldeschi, et al.
The British Journal of Ophthalmology
|
May 9, 2015
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012
Petros Perros, Miloš Žarković, Claudio Azzolini, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
European Journal of Endocrinology
|
April 14, 2018
Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism
Wilmar Wiersinga, Miloš Žarković, Luigi Bartalena, et al.
The New England Journal of Medicine
|
May 4, 2017
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J Smith, George J Kahaly, Daniel G Ezra, et al.
Ophthalmology
|
October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study
Raymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
The New England Journal of Medicine
|
January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye Disease
Raymond S Douglas, George J Kahaly, Amy Patel, et al.
European Journal of Endocrinology
|
February 27, 2008
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Luigi Bartalena, Lelio Baldeschi, Alison Dickinson, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 18, 2008
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy
Luigi Bartalena, Lelio Baldeschi, Alison J Dickinson, et al.
The British Journal of Ophthalmology
|
January 10, 2023
Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)
Anna Schuh, Goksun Ayvaz, Lelio Baldeschi, et al.
The British Journal of Ophthalmology
|
May 9, 2015
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012
Petros Perros, Miloš Žarković, Claudio Azzolini, et al.
Page
of 6